JW THERAPEUTICS
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.The company focuses on development, transformation and promotion of cell-based immunotherapies that uses chimeric antigen receptor (CAR) and T cell receptor (TCR) technologies to regulate the body's immune system, enabling doctors to save the lives of cancer patients and improve the quality of life.
JW THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-02-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.jwtherapeutics.com
Total Employee:
51+
Status:
Active
Contact:
+ 86-21-50464201
Total Funding:
190 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Global Site Tag Euro Microsoft Azure DNS US Privacy User Signal Mechanism
Similar Organizations
Amyloid Solution
Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Carrick Therapeutics
Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.
Cryofocus Biotech
Cryofocus Biotech cryoablation device manufacturer.
Dukaan®
Dukaan is a DIY platform which enables merchants with zero programming skills to set up their e-commerce store using smartphone.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
GenFleet Therapeutics
GenFleet Therapeutics is a biotechnology developer and researcher of molecular pharmaceuticals targeting cancer treatments.
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
Neukio Biotherapeutics
Neukio Biotherapeutics is a developer of allogenic immune cell therapies for treatment of cancer.
Nucros Science & Taste
Nucros is a smart-health solutions provider which links your past, present and future to offer diets.
OBiO Technology
OBiO Technology is providing overall solution of viral based gene therapy CRO services, and CDMO/CMO services.
Periotherapia
Periotherapia is a drug discovery business with triple negative breast cancer as the first indication.
Phico Therapeutics
Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.
PolyProx
PolyProx Therapeutics is a developer of a novel class of drug intended to provide new therapies for cancer treatment.
PuREC
PuREC is a developer of a culture technology intended to bring efficacy to the treatment process.
S-Alpha Therapeutics
S-Alpha Therapeutics engages in the research and development of health apps and digital therapeutics.
Shanghai Cell Therapy Group
Shanghai Cell Therapy Group is a provider of cellular diagnosis center combining cellular research and treatment services.
WonDRx
Pronounced as Wonder RX. WonDRx prescription serves as the foundation of connected healthcare, it helps optimize clinical practices.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-07-20 | Syracuse Biopharma | Syracuse Biopharma acquired by JW Therapeutics | N/A |
Investors List
ARCH Venture Partners
ARCH Venture Partners investment in Series B - JW Therapeutics
Loyal Valley Capital
Loyal Valley Capital investment in Series B - JW Therapeutics
CPE
CPE investment in Series B - JW Therapeutics
Temasek Holdings
Temasek Holdings investment in Series B - JW Therapeutics
Juno Therapeutics
Juno Therapeutics investment in Series B - JW Therapeutics
Mirae Asset Global Investments
Mirae Asset Global Investments investment in Series B - JW Therapeutics
CR-CP Life Science Fund
CR-CP Life Science Fund investment in Series B - JW Therapeutics
Sequoia Capital China
Sequoia Capital China investment in Series B - JW Therapeutics
Oriza Holdings
Oriza Holdings investment in Series B - JW Therapeutics
WuXi AppTec
WuXi AppTec investment in Series B - JW Therapeutics
Official Site Inspections
http://www.jwtherapeutics.com Semrush global rank: 6.77 M Semrush visits lastest month: 804
- Host name: 42.159.132.179
- IP address: 42.159.132.179
- Location: Shanghai China
- Latitude: 31.0449
- Longitude: 121.4012
- Timezone: Asia/Shanghai
